Overview Fundamentals API Earnings EOD API Sample Code Pricing

MIRA Pharmaceuticals Inc. Common Stock (MIRA NASDAQ) stock market data APIs

$0.7889 -0.03(-3.7%) as of July 17, 2024
Price chart is built with Anychart

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

MIRA Pharmaceuticals Inc. Common Stock Financial Data Overview

0.8201
0.7889
-
0.86
0.75
0.51-7.9799
10 421 K
14 781 K
0
-0.12
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MIRA',
Type: 'Common Stock',
Name: 'MIRA Pharmaceuticals Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01H8XP5F5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1904286',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-08-03',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
HomeCategory: NULL,
IsDelisted: false,
}

MIRA Pharmaceuticals Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.66
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get MIRA Pharmaceuticals Inc. Common Stock Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.1

Get MIRA Pharmaceuticals Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get MIRA Pharmaceuticals Inc. Common Stock latest news via APIs

Do you have any questions?
support@eodhistoricaldata.com